Back to RIGL
LORING WOLCOTT & COOLIDGE FIDUCIARY ADVISORS LLP/MA → RIGL
LORING WOLCOTT & COOLIDGE FIDUCIARY ADVISORS LLP/MA RIGL Position History
Rigel Pharmaceuticals, Inc.
Quarters held
4
Latest value
$130
Q3 2026
Peak value
$130
First seen
Q4 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q4 2025 | $101 |
| Q1 2026 | $79 |
| Q2 2026 | $106 |
| Q3 2026 | $130 |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $130 | 3 | — | — |
| Q2 2026 | $106 | 3 | — | — |
| Q1 2026 | $79 | 3 | — | — |
| Q4 2025 | $101 | 3 | — | — |
Other funds holding RIGL
$40.7M
$40.7M
$30.3M
$22.4M
$22.4M
$15.1M
$13.8M